Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 7;36(1):17.
doi: 10.1007/s12022-025-09862-3.

ABCC3 Is a Differential Marker of CYP11B2-Negative Zona Glomerulosa Cells in Human Adrenal Cortex

Yingxian Pang  1 , Sanas Mir-Bashiri  1 , Zhuolun Sun  1 , Yuhong Yang  1   2 , Isabella Castellano  3 , Thomas Knösel  4 , Martin Reincke  1 , Tracy Ann Williams  5
Affiliations

ABCC3 Is a Differential Marker of CYP11B2-Negative Zona Glomerulosa Cells in Human Adrenal Cortex

Yingxian Pang et al. Endocr Pathol. .

Abstract

ATP Binding Cassette Subfamily C Member 3 (ABCC3) is a membrane transporter that exports diverse compounds, influencing drug resistance in cancers and impacting metabolic and malignant diseases. We previously reported ABCC3 upregulation in human adrenal cells under lipid peroxidation-induced oxidative stress. We investigated ABCC3 expression and function in the human adrenal cortex in the context of primary aldosteronism, focusing on its relationship to CYP11B2 (aldosterone synthase) in zona glomerulosa (ZG) cells and aldosterone-producing lesions. ABCC3 expression in aldosterone-producing adenomas (APAs) was markedly reduced compared to the adjacent adrenal cortex, cortisol-producing adenomas, and non-functioning adenomas. The reduction in APAs showed genotypic variability: in APAs harboring KCNJ5 mutations-known drivers of autonomous aldosterone production via altered potassium channel function-ABCC3 mRNA/protein levels were significantly higher than in wild-type KCNJ5 APAs. Spatial transcriptomics and immunofluorescence colocalization revealed an inverse expression pattern between ABCC3 and CYP11B2 (aldosterone synthase) in APAs and aldosterone-producing micronodules (APMs). Notably, high ABCC3 expression was exclusively observed in adrenal ZG cells that lacked CYP11B2 expression. This expression pattern distinguishes ABCC3 from common ZG markers such as KCNJ5 and DAB2, which are expressed across adrenal ZG cells, APMs, and APA tumor cells. In cultured human adrenocortical cells, both angiotensin II stimulation and induced expression of the KCNJ5-L168R mutation resulted in upregulation of CYP11B2 transcription while concomitantly suppressing ABCC3 expression. In conclusion, ABCC3 serves as a novel marker of CYP11B2-negative ZG cells, providing a histopathological tool to differentiate normal adrenal zonation from aldosterone-producing lesions in primary aldosteronism, as well as from cortisol-producing and nonfunctional adenomas.

Keywords: ABCC3; Adrenal gland; Aldosterone-producing adenoma; Aldosterone-producing micronodule; CYP11B2; Zona glomerulosa.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics Approval: The study was conducted in accordance with local ethics committee guidelines and approved by the institutional review board (project number 379–10 and 24–0696). Competing Interests: The authors declare no competing interests.

References

    1. Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F et al (2017) Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol 69: 1811–1820. https://doi.org/10.1016/j.jacc.2017.01.052
    1. Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA (2021) Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol 9: 876–892. https://doi.org/10.1016/s2213-8587(21)00210-2
    1. Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E et al (2025) Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort. Lancet Diabetes Endocrinol 13: 119–133. https://doi.org/10.1016/s2213-8587(24)00308-5
    1. Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F et al (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 6: 41–50. https://doi.org/10.1016/s2213-8587(17)30319-4
    1. Williams TA, Gomez-Sanchez CE, Rainey WE, Giordano TJ, Lam AK, Marker A et al (2021) International Histopathology Consensus for Unilateral Primary Aldosteronism. J Clin Endocrinol Metab 106: 42–54. https://doi.org/10.1210/clinem/dgaa484

MeSH terms

Substances

LinkOut - more resources